ASCO Conference Coverage

ASTRO guidelines for endometrial cancer endorsed by ASCO

Qualifications to guidelines include stronger statements in favor of chemotherapy in some cases.

Immunotherapy combination increases progression-free survival (PFS) in advanced melanoma patients

Treating advanced melanoma patients with either a combination of nivolumab and ipilimumab, or nivolumab alone, significantly increases progression-free survival (PFS) when compared with ipilimumab alone.

ASCO: Additional tissue removal reduces further breast cancer surgery

Removing extra tissue can halve the chances of requiring a second surgery in breast cancer.

ASCO: Lymph node surgery not best option for all melanoma patients

For some patients with advanced melanoma, surgical removal of the lymph nodes surrounding their tumor may not be needed.

ASCO: PD-1 immunotherapy beneficial for patients with NSCLC

Fewer side effects, longer survival for nivolumab versus docetaxel seen in patients with non-small-cell lung cancer (NSCLC).

Hepatitis virus variations responsible for variations in liver cancer

Significant clinical variations have been identified among patients with hepatocellular carcinoma (HCC).

ASCO: Nicotinamide could help prevent non-melanoma skin cancer

A preliminary Australian study saw association between nicotinamide and lower rates of non-melanoma skin cancers.

ASCO: High-risk prostate cancer diagnosis up since new PSA recommendations

Researchers report 3 percent annual rise in intermediate- and high-risk cases

ASCO: Active surveillance for prostate cancer may decrease survival odds for some

When active surveillance is chosen, survival for intermediate-risk disease may be decreased.

ASCO: Testicular cancer history may indicate greater risk of developing prostate cancer

Individuals who've had testicular cancer may be at increased risk for prostate cancer, but the overall risk is low, according to a study.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs